Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00053131 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: sargramostim
DRUG: cytarabine
DRUG: mitoxantrone hydrochloride

Sponsor

Roswell Park Cancer Institute